{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:09:10Z","timestamp":1790179750745,"version":"4.1.0"},"reference-count":243,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118921","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:08:58Z","timestamp":1766120938000},"page":"118921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hijacking migration: CXCL12-functionalized hydrogels as a new frontier in glioblastoma therapy"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-2724","authenticated-orcid":false,"given":"Hossein","family":"Khorramdelazad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Pourtorabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ghaffarinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sedghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000531319","article-title":"Glioblastoma multiforme: the latest diagnostics and treatment techniques","volume":"108","author":"Czarnywojtek","year":"2023","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib2","article-title":"Prognostic factors and survival of recurrent glioblastoma: a systematic review","volume":"67","author":"Aman","year":"2025","journal-title":"Folia Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/cancers14020443","article-title":"Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives","volume":"14","author":"Seker-Polat","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib4","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/ijms22083863","article-title":"The importance of tumor stem cells in glioblastoma resistance to therapy","volume":"22","author":"Mattei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118921_bib5","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/cancers13122983","article-title":"Advances in chemokine signaling pathways as therapeutic targets in glioblastoma","volume":"13","author":"Urbantat","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0897.2012.01167.x","article-title":"Differential expression of CXC chemokines CXCL 10 and CXCL 12 in term and pre-term neonates and their mothers","volume":"68","author":"Aminzadeh","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12031-011-9672-6","article-title":"The SDF-1 3\u2032 a genetic variation of the chemokine SDF-1\u03b1 (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients","volume":"47","author":"Azin","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000494435","article-title":"CXCL12 and CXCR4 in the peripheral blood of patients with Parkinson\u2019s disease","volume":"25","author":"Bagheri","year":"2019","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12031-013-9954-2","article-title":"The SDF-1 3\u2032A genetic variation is correlated with elevated intra-tumor tissue and circulating concentration of CXCL12 in glial tumors: a study on Iranian anaplastic astrocytoma and glioblastoma multiforme patients","volume":"50","author":"Moosavi","year":"2013","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4161\/cbt.9.1.10342","article-title":"CXCL12\/CXCR4 promotes motility and proliferation of glioma cells","volume":"9","author":"Carmo","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2025.118921_bib11","first-page":"144","article-title":"CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment","volume":"8","author":"W\u00fcrth","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib12","first-page":"81","article-title":"Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12\/CXCR4 signaling","volume":"17","author":"Goffart","year":"2015","journal-title":"NeuroOncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib13","doi-asserted-by":"crossref","first-page":"17811","DOI":"10.1038\/s41598-025-02977-x","article-title":"GliaTrap is a biodegradable, non-swelling and non-inflammatory hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells","volume":"15","author":"Suita","year":"2025","journal-title":"Sci. Rep."},{"issue":"5-6","key":"10.1016\/j.biopha.2025.118921_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18632\/oncoscience.311","article-title":"Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide","volume":"3","author":"Rios","year":"2016","journal-title":"Oncoscience"},{"issue":"14","key":"10.1016\/j.biopha.2025.118921_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300671","article-title":"Development of a synthetic, injectable hydrogel to capture residual glioblastoma and glioblastoma stem-like cells with CXCL12-mediated chemotaxis","volume":"12","author":"Khan","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.118921_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135894","article-title":"A thermo-responsive chemically crosslinked long-term-release chitosan hydrogel system increases the efficiency of synergy chemo-immunotherapy in treating brain tumors","volume":"280","author":"Chuang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118921_bib17","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1039\/D1BM00896J","article-title":"Local delivery to malignant brain tumors: potential biomaterial-based therapeutic\/adjuvant strategies","volume":"9","author":"Alghamdi","year":"2021","journal-title":"Biomater. Sci."},{"issue":"48","key":"10.1016\/j.biopha.2025.118921_bib18","doi-asserted-by":"crossref","first-page":"65754","DOI":"10.1021\/acsami.4c11855","article-title":"Hydrogel applications in the diagnosis and treatment of glioblastoma","volume":"16","author":"Zhang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"22","key":"10.1016\/j.biopha.2025.118921_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101329","article-title":"Extracellular matrix-mimetic hydrogels for treating neural tissue injury: a focus on fibrin, hyaluronic acid, and elastin-like polypeptide hydrogels","volume":"10","author":"Nelson","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"15-16","key":"10.1016\/j.biopha.2025.118921_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.lfs.2011.04.022","article-title":"Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma","volume":"89","author":"Alves","year":"2011","journal-title":"Life Sci."},{"issue":"23","key":"10.1016\/j.biopha.2025.118921_bib21","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1101\/gad.1725808","article-title":"Modular control of endothelial sheet migration","volume":"22","author":"Vitorino","year":"2008","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib22","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/ijms23052509","article-title":"Friends with benefits: chemokines, glioblastoma-associated microglia\/macrophages, and tumor microenvironment","volume":"23","author":"Codrici","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/ijms21061932","article-title":"Tumor cell invasion in glioblastoma","volume":"21","author":"Vollmann-Zwerenz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118921_bib24","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029","article-title":"Collective invasion in breast cancer requires a conserved basal epithelial program","volume":"155","author":"Cheung","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/pharmaceutics14061189","article-title":"Drug delivery systems in the development of novel strategies for glioblastoma treatment","volume":"14","author":"El Kheir","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/cells10030607","article-title":"The role of cytokines and chemokines in shaping the immune microenvironment of glioblastoma: implications for immunotherapy","volume":"10","author":"Yeo","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000533130","article-title":"ABCF1\/CXCL12\/CXCR4 enhances glioblastoma cell proliferation, migration, and invasion by activating the PI3K\/AKT signal pathway","volume":"46","author":"Yin","year":"2024","journal-title":"Dev. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/cancers11030272","article-title":"Targeting the post-irradiation tumor microenvironment in glioblastoma via inhibition of CXCL12","volume":"11","author":"Giordano","year":"2019","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.biopha.2025.118921_bib29","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib30","doi-asserted-by":"crossref","first-page":"C175","DOI":"10.1152\/ajpcell.00344.2009","article-title":"CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity","volume":"299","author":"Sciaccaluga","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118921_bib31","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"37","key":"10.1016\/j.biopha.2025.118921_bib32","doi-asserted-by":"crossref","first-page":"32188","DOI":"10.1074\/jbc.M111.277038","article-title":"CXCR7\/CXCR4 heterodimer constitutively recruits \u03b2-arrestin to enhance cell migration","volume":"286","author":"D\u00e9caillot","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib33","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/1078-0432.CCR-15-2888","article-title":"Survival and proliferation of neural progenitor\u2013derived glioblastomas under hypoxic stress is controlled by a Cxcl12\/Cxcr4 autocrine-positive feedback mechanism","volume":"23","author":"Calinescu","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118921_bib34","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3390\/cancers16112089","article-title":"Understanding the significance of hypoxia-inducible factors (HIFs) in glioblastoma: a systematic review","volume":"16","author":"Begagi\u0107","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2015.02.005","article-title":"VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGF\u03b2R signaling-dependent manner","volume":"360","author":"Pham","year":"2015","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib36","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/cancers14092314","article-title":"CXCR4\/CXCL12 activities in the tumor microenvironment and implications for tumor immunotherapy","volume":"14","author":"Mezzapelle","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118921_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217185","article-title":"Suppressive immune microenvironment and CART therapy for glioblastoma: future prospects and challenges","volume":"600","author":"Lu","year":"2024","journal-title":"Cancer Lett."},{"issue":"18","key":"10.1016\/j.biopha.2025.118921_bib38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/cells14181458","article-title":"Tumor-associated macrophages in glioblastoma: mechanisms of tumor progression and therapeutic strategies","volume":"14","author":"Chen","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118921_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117534","article-title":"CXCL12\/CXCR4 axis in the microenvironment of solid tumors: a critical mediator of metastasis","volume":"249","author":"Mortezaee","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118921_bib40","first-page":"4953","article-title":"CXCR4 in breast cancer: oncogenic role and therapeutic targeting","author":"Xu","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/JLB.2BT1018-715RR","article-title":"At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer","volume":"109","author":"Luker","year":"2021","journal-title":"J. Leucoc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12935-024-03584-y","article-title":"A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer","volume":"25","author":"Khorramdelazad","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/glia.21127","article-title":"A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target","volume":"59","author":"Schulte","year":"2011","journal-title":"Glia"},{"issue":"19","key":"10.1016\/j.biopha.2025.118921_bib44","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1158\/1078-0432.CCR-18-1025","article-title":"Phase I and biomarker study of plerixafor and bevacizumab in recurrent high-grade glioma","volume":"24","author":"Lee","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib45","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s12253-020-00827-x","article-title":"Novel CXCR4 inhibitor CPZ1344 inhibits the proliferation, migration and angiogenesis of glioblastoma","volume":"26","author":"Luo","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695528","article-title":"The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models","volume":"39","author":"Gravina","year":"2017","journal-title":"Tumor Biol."},{"issue":"3-4","key":"10.1016\/j.biopha.2025.118921_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.18632\/genesandcancer.105","article-title":"Epigenetically silenced GNG4 inhibits SDF1\u03b1\/CXCR4 signaling in mesenchymal glioblastoma","volume":"7","author":"Pal","year":"2016","journal-title":"Genes Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11060-019-03172-5","article-title":"Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment","volume":"143","author":"Wu","year":"2019","journal-title":"J. neuroOncol."},{"key":"10.1016\/j.biopha.2025.118921_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.actbio.2024.02.007","article-title":"Nanoparticle-mediated blockade of CXCL12\/CXCR4 signaling enhances glioblastoma immunotherapy: monitoring early responses with MRI radiomics","volume":"177","author":"Wei","year":"2024","journal-title":"Acta Biomater."},{"issue":"23","key":"10.1016\/j.biopha.2025.118921_bib50","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1158\/1078-0432.CCR-19-1421","article-title":"Macrophage exclusion after radiation therapy (MERT): a first in human phase I\/II trial using a CXCR4 inhibitor in glioblastoma","volume":"25","author":"Thomas","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13046-016-0326-y","article-title":"Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model","volume":"35","author":"Mercurio","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.biopha.2025.118921_bib52","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.18632\/oncotarget.2443","article-title":"Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma","volume":"5","author":"Barone","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118921_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113483","article-title":"Catalase application in cancer therapy: simultaneous focusing on hypoxia attenuation and macrophage reprogramming","volume":"153","author":"Najafi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib54","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1021\/acsnano.1c07492","article-title":"Systemic delivery of an adjuvant CXCR4\u2013CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy","volume":"16","author":"Alghamri","year":"2022","journal-title":"ACS nano"},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/md20050306","article-title":"AlgaL Polysaccharides-based Hydrogels: Extraction, Synthesis, Characterization, and Applications","volume":"20","author":"Lin","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.biopha.2025.118921_bib56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijbiomac.2020.01.227","article-title":"Hydrophobically-modified gelatin hydrogel as a carrier for charged hydrophilic drugs and hydrophobic drugs","volume":"149","author":"Takei","year":"2020","journal-title":"Int J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/pharmaceutics13030357","article-title":"Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management","volume":"13","author":"Jacob","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118921_bib58","series-title":"Local treatment of glioblastoma with a hydrogel designed to recruit and efficiently damage cancer cells","author":"Ribeiro","year":"2021"},{"issue":"20","key":"10.1016\/j.biopha.2025.118921_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202001055","article-title":"Injectable biomaterials for treatment of glioblastoma","volume":"7","author":"Anderson","year":"2020","journal-title":"Adv. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092902","article-title":"Hydrogels: properties and applications in biomedicine","volume":"27","author":"Ho","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118921_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2023.106145","article-title":"Hydrogels: An overview of its classifications, properties, and applications","volume":"147","author":"Mehta","year":"2023","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.biopha.2025.118921_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.133195","article-title":"Plant-derived adhesive hydrogel with high stretchability and conductivity for wearable electronics","volume":"379","author":"Yuan","year":"2023","journal-title":"Sens. Actuators B Chem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200332","article-title":"Biomechanical and Biological Characterization of XGel, a Human-Derived Hydrogel for Stem Cell Expansion and Tissue Engineering","volume":"7","author":"Belgodere","year":"2023","journal-title":"Adv. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib64","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/acs.molpharmaceut.7b01114","article-title":"Sustained delivery of doxorubicin via acetalated dextran scaffold prevents glioblastoma recurrence after surgical resection","volume":"15","author":"Graham-Gurysh","year":"2018","journal-title":"Mol. Pharm."},{"issue":"16","key":"10.1016\/j.biopha.2025.118921_bib65","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.2174\/0929867326666191016112828","article-title":"Natural hydrogels applied in photodynamic therapy","volume":"27","author":"Feng","year":"2020","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.biopha.2025.118921_bib66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijbiomac.2019.04.197","article-title":"Scaffolding polymeric biomaterials: are naturally occurring biological macromolecules more appropriate for tissue engineering?","volume":"134","author":"Abbasian","year":"2019","journal-title":"Int J. Biol. Macromol."},{"issue":"16","key":"10.1016\/j.biopha.2025.118921_bib67","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.2174\/0929867326666190816125144","article-title":"Natural-based hydrogels: a journey from simple to smart networks for medical examination","volume":"27","author":"Tavakoli","year":"2020","journal-title":"Curr. Med Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/polym14091690","article-title":"Antibacterial and antifungal properties of modified chitosan nonwovens","volume":"14","author":"Sikorski","year":"2022","journal-title":"Polymers"},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102243","article-title":"Injectable pH Thermo-Responsive Hydrogel Scaffold for Tumoricidal Neural Stem Cell Therapy for Glioblastoma Multiforme","volume":"14","author":"King","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118921_bib70","article-title":"Engineering GliaTrap: A biodegradable non-swelling hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells","author":"Suita","year":"2023","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib71","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1039\/C8BM01246F","article-title":"Advances in crosslinking strategies of biomedical hydrogels","volume":"7","author":"Hu","year":"2019","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118921_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071743","article-title":"Hyaluronic Acid: Redefining Its Role","volume":"9","author":"Abatangelo","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib73","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/cam.2.3.6320","article-title":"Role of hyaluronan in glioma invasion","volume":"2","author":"Park","year":"2008","journal-title":"Cell Adh Migr."},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib74","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1541-7786.MCR-13-0629","article-title":"CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility","volume":"12","author":"Kim","year":"2014","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118921_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fmats.2018.00039","article-title":"Influence of Hyaluronic Acid Transitions in Tumor Microenvironment on Glioblastoma Malignancy and Invasive Behavior","volume":"5","author":"Chen","year":"2018","journal-title":"Front Mater."},{"key":"10.1016\/j.biopha.2025.118921_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119371","article-title":"Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens","volume":"219","author":"Pedron","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118921_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113951","article-title":"Rationally designed drug delivery systems for the local treatment of resected glioblastoma","volume":"177","author":"Bastiancich","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"17","key":"10.1016\/j.biopha.2025.118921_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900670","article-title":"Natural polymer-based hydrogels with enhanced mechanical performances: preparation, structure, and property","volume":"8","author":"Bao","year":"2019","journal-title":"Adv. Health Mater."},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/gels8080496","article-title":"Biomimetic hydrogels in the study of cancer mechanobiology: overview, biomedical applications, and future perspectives","volume":"8","author":"Sahan","year":"2022","journal-title":"Gels"},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10856-019-6318-7","article-title":"Overview of natural hydrogels for regenerative medicine applications","volume":"30","author":"Catoira","year":"2019","journal-title":"J. Mater. Sci. Mater. Med"},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib81","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1021\/acsnano.1c04206","article-title":"Functional Hydrogels as Wound Dressing to Enhance Wound Healing","volume":"15","author":"Liang","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib82","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijpharm.2018.07.033","article-title":"Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival","volume":"548","author":"Zhao","year":"2018","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2025.118921_bib83","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.2147\/IJN.S248987","article-title":"Smart hydrogels - synthetic stimuli-responsive antitumor drug release systems","volume":"15","author":"Kasi\u0144ski","year":"2020","journal-title":"Int J. Nanomed."},{"issue":"48","key":"10.1016\/j.biopha.2025.118921_bib84","doi-asserted-by":"crossref","first-page":"65754","DOI":"10.1021\/acsami.4c11855","article-title":"Hydrogel Applications in the Diagnosis and Treatment of Glioblastoma","volume":"16","author":"Zhang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/gels8030167","article-title":"Versatility of hydrogels: from synthetic strategies, classification, and properties to biomedical applications","volume":"8","author":"Ahmad","year":"2022","journal-title":"Gels"},{"issue":"36","key":"10.1016\/j.biopha.2025.118921_bib86","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1016\/j.biomaterials.2008.08.037","article-title":"Biodegradable poly(polyol sebacate) polymers","volume":"29","author":"Bruggeman","year":"2008","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/gels10040216","article-title":"Evolution of Hybrid Hydrogels: Next-Generation Biomaterials for Drug Delivery and Tissue Engineering","volume":"10","author":"Rana","year":"2024","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/bm501361c","article-title":"Opportunities for multicomponent hybrid hydrogels in biomedical applications","volume":"16","author":"Lau","year":"2015","journal-title":"Biomacromolecules"},{"issue":"24","key":"10.1016\/j.biopha.2025.118921_bib89","doi-asserted-by":"crossref","first-page":"27623","DOI":"10.1021\/acsami.2c05147","article-title":"Multifunctional Hybrid Hydrogel System Enhanced the Therapeutic Efficacy of Treatments for Postoperative Glioma","volume":"14","author":"Cao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.118921_bib90","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jconrel.2022.03.050","article-title":"In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma","volume":"345","author":"Wang","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2025.118921_bib91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.actbio.2020.11.030","article-title":"Biocompatible copolymer formulations to treat glioblastoma multiforme","volume":"121","author":"Erthal","year":"2021","journal-title":"Acta Biomater."},{"issue":"23","key":"10.1016\/j.biopha.2025.118921_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313160","article-title":"Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma","volume":"22","author":"Pena","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib93","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ac5574","article-title":"Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity","volume":"17","author":"Kyriakides","year":"2022","journal-title":"Biomed. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-016-2096-y","article-title":"The brain tissue response to surgical injury and its possible contribution to glioma recurrence","volume":"128","author":"Hamard","year":"2016","journal-title":"J. Neurooncol"},{"issue":"18","key":"10.1016\/j.biopha.2025.118921_bib95","article-title":"Biodegradable Natural Hydrogels for Tissue Engineering, Controlled Release, and Soil Remediation","volume":"16","author":"Garcia-Garcia","year":"2024","journal-title":"Polym. (Basel)"},{"issue":"20","key":"10.1016\/j.biopha.2025.118921_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202001055","article-title":"Injectable biomaterials for treatment of glioblastoma","volume":"7","author":"Anderson","year":"2020","journal-title":"Adv. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030603","article-title":"Hydrogels and their applications in targeted drug delivery","volume":"24","author":"Narayanaswamy","year":"2019","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.biopha.2025.118921_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/polym14163368","article-title":"Intracranial in situ thermosensitive hydrogel delivery of temozolomide accomplished by PLGA-PEG-PLGA triblock copolymer blending for GBM treatment","volume":"14","author":"Gu","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.biopha.2025.118921_bib99","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2023.05.046","article-title":"Reduced malignant glioblastoma recurrence post-resection through the anti-CD47 antibody and Temozolomide co-embedded in-situ hydrogel system","volume":"359","author":"Ye","year":"2023","journal-title":"J. Control Release"},{"issue":"7","key":"10.1016\/j.biopha.2025.118921_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/polym15071795","article-title":"pH-sensitive degradable oxalic acid crosslinked hyperbranched polyglycerol hydrogel for controlled drug release","volume":"15","author":"de Campos","year":"2023","journal-title":"Polymers"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801391","article-title":"Designing Next-Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the Clinic","volume":"8","author":"Tabet","year":"2019","journal-title":"Adv. Health Mater."},{"issue":"7","key":"10.1016\/j.biopha.2025.118921_bib102","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1021\/mp5000828","article-title":"Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels","volume":"11","author":"Wang","year":"2014","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202147","article-title":"Dynamically Crosslinked Poly(ethylene-glycol) Hydrogels Reveal a Critical Role of Viscoelasticity in Modulating Glioblastoma Fates and Drug Responses in 3D","volume":"12","author":"Sinha","year":"2023","journal-title":"Adv. Health Mater."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/gels8050301","article-title":"Current understanding of hydrogel for drug release and tissue engineering","volume":"8","author":"Lei","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.biopha.2025.118921_bib105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijbiomac.2014.12.008","article-title":"Effect of different cross-linking methods and processing parameters on drug release from hydrogel beads","volume":"74","author":"Mitra","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"37","key":"10.1016\/j.biopha.2025.118921_bib106","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1016\/j.biomaterials.2014.08.001","article-title":"The control of cargo release from physically crosslinked hydrogels by crosslink dynamics","volume":"35","author":"Appel","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/gels4030062","article-title":"Hydrogel-based drug delivery nanosystems for the treatment of brain tumors","volume":"4","author":"Basso","year":"2018","journal-title":"Gels"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030503","article-title":"Theranostic design of angiopep-2 conjugated hyaluronic acid nanoparticles (Thera-ANG-cHANPs) for dual targeting and boosted imaging of glioma cells","volume":"13","author":"Costagliola di Polidoro","year":"2021","journal-title":"Cancers"},{"issue":"5-6","key":"10.1016\/j.biopha.2025.118921_bib109","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/ten.tea.2020.0110","article-title":"Matrix Stiffness Modulates Patient-Derived Glioblastoma Cell Fates in Three-Dimensional Hydrogels","volume":"27","author":"Wang","year":"2021","journal-title":"Tissue Eng. Part A"},{"issue":"24","key":"10.1016\/j.biopha.2025.118921_bib110","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1039\/D3TB00066D","article-title":"Evaluating glioblastoma tumour sphere growth and migration in interaction with astrocytes using 3D collagen-hyaluronic acid hydrogels","volume":"11","author":"Cui","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"12","key":"10.1016\/j.biopha.2025.118921_bib111","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.28.12.126007","article-title":"Development of hydrogel-based standards and phantoms for non-linear imaging at depth","volume":"28","author":"Haseeb","year":"2023","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.biopha.2025.118921_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1134109","article-title":"MRI radiomics and potential applications to glioblastoma","volume":"13","author":"Hooper","year":"2023","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ph13020019","article-title":"Peptide-based soft hydrogels modified with gadolinium complexes as MRI contrast agents","volume":"13","author":"Gallo","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118921_bib114","doi-asserted-by":"crossref","first-page":"37906","DOI":"10.1038\/srep37906","article-title":"A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRI","volume":"6","author":"Russo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118921_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.126214","article-title":"Bright luminescent Zn2GeO4: Mn NP\/MXene hydrogel-based ECL biosensor for glioblastoma diagnosis","volume":"276","author":"Deng","year":"2024","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib116","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.3390\/ijms16035517","article-title":"Three-dimensional cell culture: a breakthrough in vivo","volume":"16","author":"Antoni","year":"2015","journal-title":"Int J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.biopha.2025.118921_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212200","article-title":"3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib118","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/acsmaterialsau.3c00029","article-title":"Engineered In Vitro Tumor Model Recapitulates Molecular Signatures of Invasion in Glioblastoma","volume":"3","author":"Smith","year":"2023","journal-title":"ACS Mater. Au"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib119","doi-asserted-by":"crossref","first-page":"17727","DOI":"10.1038\/s41598-021-97059-z","article-title":"Gelatin methacrylate hydrogels culture model for glioblastoma cells enriches for mesenchymal-like state and models interactions with immune cells","volume":"11","author":"Shah","year":"2021","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.biopha.2025.118921_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311109","article-title":"Intracavitary spraying of nanoregulator-encased hydrogel modulates cholesterol metabolism of glioma-supportive macrophage for postoperative glioblastoma immunotherapy","volume":"36","author":"Dong","year":"2024","journal-title":"Adv. Mater."},{"issue":"43","key":"10.1016\/j.biopha.2025.118921_bib121","article-title":"Immunostimulant in situ hydrogel improves synergetic radioimmunotherapy of malignant glioblastoma relapse post-resection","volume":"32","author":"Sun","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib122","article-title":"Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis","volume":"18","author":"Wang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10676","article-title":"Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastoma","volume":"9","author":"Kass","year":"2024","journal-title":"Bioeng. Transl. Med."},{"issue":"12","key":"10.1016\/j.biopha.2025.118921_bib124","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1007\/s13346-023-01456-y","article-title":"Local delivery of doxorubicin prodrug via lipid nanocapsule\u2013based hydrogel for the treatment of glioblastoma","volume":"14","author":"Wang","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"issue":"12","key":"10.1016\/j.biopha.2025.118921_bib125","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s10439-024-03601-1","article-title":"Development of an Injectable Hydrogel for Histotripsy Ablation Toward Future Glioblastoma Therapy Applications","volume":"52","author":"Khan","year":"2024","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.biopha.2025.118921_bib126","article-title":"An injectable in situ hydrogel platform for sustained drug release against Glioblastoma","volume":"95","author":"Yue","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309610","article-title":"Implantable Ultrasound-Powered MXene\/PVA Hydrogel-Based Generator for Treatment of Glioblastoma","volume":"12","author":"Hu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118921_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140025","article-title":"Targeting JAK\/STAT3 in glioblastoma cells using an alginate-PNIPAm molecularly imprinted hydrogel for the sustained release of ruxolitinib","volume":"298","author":"B\u0103r\u0103ian","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/gels4030062","article-title":"Hydrogel-based drug delivery nanosystems for the treatment of brain tumors","volume":"4","author":"Basso","year":"2018","journal-title":"Gels"},{"key":"10.1016\/j.biopha.2025.118921_bib130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2017.08.019","article-title":"Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection","volume":"264","author":"Bastiancich","year":"2017","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14737175.3.4.533","article-title":"Local delivery of antineoplastic agents using biodegradable polymers for the treatment of malignant brain tumors","volume":"3","author":"Legnani","year":"2003","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.biopha.2025.118921_bib132","series-title":"Drug Delivery Systems in Cancer Therapy","first-page":"215","article-title":"Gliadel\u00ae: A New Method for the Treatment of Malignant Brain Tumors","author":"DiMeco","year":"2004"},{"key":"10.1016\/j.biopha.2025.118921_bib133","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2015.05.272","article-title":"Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma","volume":"210","author":"Fourniols","year":"2015","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib134","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.7150\/thno.19856","article-title":"Rapid in situ MRI traceable gel-forming dual-drug delivery for synergistic therapy of brain tumor","volume":"7","author":"Lin","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118921_bib135","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2147\/IJN.S348559","article-title":"Supramolecular hydrogel based post-surgical implant system for hydrophobic drug delivery against glioma recurrence","author":"Wanjale","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib136","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s13346-022-01220-8","article-title":"Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model","volume":"13","author":"Sandbhor","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2025.118921_bib137","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ijbiomac.2018.05.079","article-title":"Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study","volume":"116","author":"Khan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118921_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114898","article-title":"Intranasal delivery of temozolomide and disulfiram in situ gel combined with copper for enhanced glioblastoma therapy","author":"Qu","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"04","key":"10.1016\/j.biopha.2025.118921_bib139","article-title":"Formulation design and development of anti-EGFR-BSA-CYP-SLNs In Situ gel for nasal administration","volume":"10","author":"Bhattacharya","year":"2016","journal-title":"Asian J. Pharm."},{"issue":"19","key":"10.1016\/j.biopha.2025.118921_bib140","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.3390\/cancers16193300","article-title":"Blood\u2013brain barrier conquest in glioblastoma nanomedicine: strategies, clinical advances, and emerging challenges","volume":"16","author":"Duan","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib141","first-page":"373","article-title":"Hydrogel-based controlled drug delivery for cancer treatment: a review","volume":"17","author":"Sun","year":"2019","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib142","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.7150\/thno.82005","article-title":"Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment","volume":"13","author":"Iturrioz-Rodr\u00edguez","year":"2023","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.biopha.2025.118921_bib143","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.biomaterials.2009.02.030","article-title":"Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme","volume":"30","author":"Ong","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib144","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijpharm.2018.07.033","article-title":"Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival","volume":"548","author":"Zhao","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14791\/btrt.2022.0017","article-title":"Local drug delivery strategies for glioblastoma treatment","volume":"10","author":"Cha","year":"2022","journal-title":"Brain Tumor Res. Treat."},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib146","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1248\/cpb.58.1142","article-title":"Treatment of rat brain tumors using sustained-release of camptothecin from poly (lactic-co-glycolic acid) microspheres in a thermoreversible hydrogel","volume":"58","author":"Ozeki","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.biopha.2025.118921_bib147","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jconrel.2016.01.054","article-title":"Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma","volume":"225","author":"Bastiancich","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib148","doi-asserted-by":"crossref","first-page":"41090","DOI":"10.1038\/srep41090","article-title":"Synergistically enhanced selective intracellular uptake of anticancer drug carrier comprising folic acid-conjugated hydrogels containing magnetite nanoparticles","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib149","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/10717544.2013.876460","article-title":"Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1","volume":"22","author":"Baklaushev","year":"2015","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib150","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/acs.biomac.4c00722","article-title":"Stimuli-responsive polymeric nanocarriers accelerate on-demand drug release to combat glioblastoma","volume":"25","author":"Ismail","year":"2024","journal-title":"Biomacromolecules"},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib151","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.chempr.2018.07.002","article-title":"Multi-stimuli-responsive polymer particles, films, and hydrogels for drug delivery","volume":"4","author":"Fu","year":"2018","journal-title":"Chem"},{"key":"10.1016\/j.biopha.2025.118921_bib152","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jconrel.2022.07.011","article-title":"Dual-sensitive drug-loaded hydrogel system for local inhibition of post-surgical glioma recurrence","volume":"349","author":"Chen","year":"2022","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib153","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/pharmaceutics14102243","article-title":"Injectable pH thermo-responsive hydrogel scaffold for tumoricidal neural stem cell therapy for glioblastoma multiforme","volume":"14","author":"King","year":"2022","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.biopha.2025.118921_bib154","article-title":"A tumor microenvironments-adapted polypeptide hydrogel\/nanogel composite boosts antitumor molecularly targeted inhibition and immunoactivation","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.biopha.2025.118921_bib155","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1039\/D0BM01943G","article-title":"Hydrogels to engineer tumor microenvironments in vitro","volume":"9","author":"Fernando","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2025.118921_bib156","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.actbio.2015.12.002","article-title":"A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan","volume":"31","author":"Cun","year":"2016","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib157","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12951-024-02871-0","article-title":"Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment","volume":"22","author":"Hou","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/gels10020114","article-title":"Advances in Hydrogels for Meniscus Tissue Engineering: A Focus on Biomaterials, Crosslinking, Therapeutic Additives","volume":"10","author":"Zhou","year":"2024","journal-title":"Gels"},{"issue":"15","key":"10.1016\/j.biopha.2025.118921_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35524","article-title":"CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization","volume":"10","author":"Portella","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib160","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1021\/acsbiomaterials.2c01310","article-title":"Investigating Trans-differentiation of Glioblastoma Cells in an In Vitro 3D Model of the Perivascular Niche","volume":"9","author":"Hatlen","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib161","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.2908","article-title":"The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K\/AKT signalling. The","volume":"224","author":"Ping","year":"2011","journal-title":"J. Pathol."},{"issue":"15","key":"10.1016\/j.biopha.2025.118921_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35524","article-title":"CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization","volume":"10","author":"Portella","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12040356","article-title":"Characterization and Mathematical Modeling of Alginate\/Chitosan-Based Nanoparticles Releasing the Chemokine CXCL12 to Attract Glioblastoma Cells","volume":"12","author":"Gascon","year":"2020","journal-title":"Pharmaceutics"},{"issue":"36","key":"10.1016\/j.biopha.2025.118921_bib164","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1039\/C6TB01083K","article-title":"Glioma cell invasion is significantly enhanced in composite hydrogel matrices composed of chondroitin 4-and 4, 6-sulfated glycosaminoglycans","volume":"4","author":"Logun","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2025.118921_bib165","series-title":"Sulfated Chondroitin Sulfate Glycosaminoglycans in Glioblastoma Progression","author":"Logun","year":"2021"},{"key":"10.1016\/j.biopha.2025.118921_bib166","unstructured":"Logun, M.T., Elucidating the role of chondroitin sulfate glycosaminoglycans in promoting glioma cell invasion. 2016."},{"issue":"6_ement","key":"10.1016\/j.biopha.2025.118921_bib167","article-title":"CXCL12-loaded-hydrogel (CLG) in vivo modifies lung metastatic niche toward an immunoactive microenvironment reducing lung metastasis development","volume":"84","author":"Guardascione","year":"2024","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.biopha.2025.118921_bib168","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3390\/cells13171404","article-title":"3D-bioprinted Co-cultures of glioblastoma Multiforme and mesenchymal stromal cells indicate a role for perivascular niche cells in shaping glioma chemokine microenvironment","volume":"13","author":"Zielniok","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib169","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1021\/acsbiomaterials.4c00041","article-title":"Open-top patterned hydrogel-laden 3D glioma cell cultures for creation of dynamic chemotactic gradients to direct cell migration","volume":"10","author":"Rane","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biopha.2025.118921_bib170","article-title":"Glioblastoma drives protease-independent extracellular matrix invasion of microglia","volume":"31","author":"Chang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2025.118921_bib171","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biomaterials.2018.07.048","article-title":"A three-dimensional (3D) organotypic microfluidic model for glioma stem cells\u2013Vascular interactions","volume":"198","author":"Truong","year":"2019","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib172","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.7150\/thno.22736","article-title":"Targeting tumor hypoxia using nanoparticle-engineered CXCR4-overexpressing adipose-derived stem cells","volume":"8","author":"Jiang","year":"2018","journal-title":"Theranostics"},{"issue":"22","key":"10.1016\/j.biopha.2025.118921_bib173","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212150","article-title":"Chemoattraction of Neoplastic Glial Cells with CXCL10, CCL2 and CCL11 as a Paradigm for a Promising Therapeutic Approach for Primary Brain Tumors","volume":"22","author":"D\u00e9ry","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118921_bib174","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315038","article-title":"CXCL12 impact on glioblastoma cells behaviors under dynamic culture conditions: Insights for developing new therapeutic approaches","volume":"19","author":"El Kheir","year":"2024","journal-title":"Plos One"},{"key":"10.1016\/j.biopha.2025.118921_bib175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.gene.2017.10.015","article-title":"The role of CXCL12 in tumor microenvironment","volume":"641","author":"Meng","year":"2018","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib176","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1038\/s41598-018-35141-9","article-title":"Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model","volume":"8","author":"Cornelison","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib177","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.364","article-title":"Opposing effects of high-and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44","volume":"4","author":"Fuchs","year":"2013","journal-title":"Cell death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101578","article-title":"A micro-environment regulator for filling the clinical treatment gap after a glioblastoma operation","volume":"11","author":"Zhang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib179","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3747\/co.2007.147","article-title":"Gliadel wafers in the treatment of malignant glioma: a systematic review","volume":"14","author":"Perry","year":"2007","journal-title":"Curr. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118921_bib180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc.2017.32","article-title":"Common pitfalls in preclinical cancer target validation","volume":"17","author":"Kaelin","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"354","key":"10.1016\/j.biopha.2025.118921_bib181","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6853","article-title":"Origin of the U87MG glioma cell line: Good news and bad news","volume":"8","author":"Allen","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"11-12","key":"10.1016\/j.biopha.2025.118921_bib182","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2025.118921_bib183","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actbio.2023.10.002","article-title":"Injectable hydrogels for personalized cancer immunotherapies","volume":"172","author":"Mohaghegh","year":"2023","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210707","article-title":"Hydrogel-based growth factor delivery platforms: strategies and recent advances","volume":"36","author":"Shan","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2025.118921_bib185","article-title":"Correction: Mechanism underlying the involvement of CXCR4\/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118921_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2023.1227776","article-title":"Impact of simulated brain interstitial fluid flow on the chemokine CXCL12 release from an alginate-based hydrogel in a new 3D in vitro model","volume":"3","author":"El Kheir","year":"2023","journal-title":"Front. Drug Deliv."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib187","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/jbm.a.34364","article-title":"Performance optimization of injectable chitosan hydrogel by combining physical and chemical triple crosslinking structure","volume":"101","author":"Chen","year":"2013","journal-title":"J. Biomed. Mater. Res. Part A"},{"issue":"44","key":"10.1016\/j.biopha.2025.118921_bib188","doi-asserted-by":"crossref","first-page":"60992","DOI":"10.1021\/acsami.4c12851","article-title":"High ion-conductive hydrogel: soft, elastic, with wide humidity tolerance and long-term stability","volume":"16","author":"Lu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib189","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1021\/acsbiomaterials.9b01139","article-title":"Modulation of human CXCL12 binding properties to glycosaminoglycans to enhance chemotactic gradients","volume":"5","author":"Spiller","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib190","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1073\/pnas.1215498110","article-title":"Hydrogel drug delivery system with predictable and tunable drug release and degradation rates","volume":"110","author":"Ashley","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6685","key":"10.1016\/j.biopha.2025.118921_bib191","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib192","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2017.06.036","article-title":"Evolution of the human nervous system function, structure, and development","volume":"170","author":"Sousa","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib193","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuron.2015.12.008","article-title":"The cellular and molecular landscapes of the developing human central nervous system","volume":"89","author":"Silbereis","year":"2016","journal-title":"Neuron"},{"issue":"19","key":"10.1016\/j.biopha.2025.118921_bib194","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1158\/1078-0432.CCR-14-0914","article-title":"Molecular pathways: targeting the CXCR4\u2013CXCL12 axis\u2014untapped potential in the tumor microenvironment","volume":"21","author":"Scala","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib195","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/cancers13030469","article-title":"The CXCL12 crossroads in cancer stem cells and their niche","volume":"13","author":"L\u00f3pez-Gil","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib196","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1189\/jlb.0909602","article-title":"The multiple faces of CXCL12 (SDF-1\u03b1) in the regulation of immunity during health and disease","volume":"88","author":"Karin","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2025.118921_bib197","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2016.06.006","article-title":"CXCR4 signaling in health and disease","volume":"177","author":"Pozzobon","year":"2016","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib198","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/157489212801820039","article-title":"CXCR4 inhibitors: tumor vasculature and therapeutic challenges","volume":"7","author":"de Nigris","year":"2012","journal-title":"Recent Pat. antiCancer Drug Discov."},{"issue":"3","key":"10.1016\/j.biopha.2025.118921_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059750","article-title":"Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rb\/rbw001","article-title":"Future challenges in the in vitro and in vivo evaluation of biomaterial biocompatibility","volume":"3","author":"Anderson","year":"2016","journal-title":"Regen. Biomater."},{"issue":"4","key":"10.1016\/j.biopha.2025.118921_bib201","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/acs.accounts.6b00536","article-title":"Designing hydrogels for on-demand therapy","volume":"50","author":"Oliva","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib202","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/pharmaceutics14081541","article-title":"Recent advances in CXCL12\/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy","volume":"14","author":"Zhao","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/1061186X.2024.2345235","article-title":"A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy","volume":"32","author":"Alcantara","year":"2024","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib204","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10856-020-06401-w","article-title":"Natural hydrogels R&D process: Technical and regulatory aspects for industrial implementation","volume":"31","author":"Catoira","year":"2020","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"13","key":"10.1016\/j.biopha.2025.118921_bib205","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201901994","article-title":"Additive manufacturing of precision biomaterials","volume":"32","author":"Guzzi","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2025.118921_bib206","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.034","article-title":"Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations","volume":"306","author":"Cooper","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib207","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/13543770802553483","article-title":"Recent patents regarding the discovery of small molecule CXCR4 antagonists","volume":"19","author":"Mosley","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2025.118921_bib208","article-title":"Hydrogels for tissue engineering: addressing key design needs toward clinical translation","volume":"10","author":"Xu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib209","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-024-01852-x","article-title":"Harnessing the potential of hydrogels for advanced therapeutic applications: Current achievements and future directions","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/cancers14010086","article-title":"CXCL12 in pancreatic cancer: its function and potential as a therapeutic drug target","volume":"14","author":"Malik","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118921_bib211","series-title":"Seminars in cancer biology","article-title":"The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis","author":"Li","year":"2009"},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib212","first-page":"1348","article-title":"CXCL12 mediates apoptosis resistance in rat C6 glioma cells","volume":"27","author":"Hattermann","year":"2012","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib213","first-page":"66","article-title":"CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone","volume":"19","author":"Goffart","year":"2017","journal-title":"NeuroOncology"},{"issue":"12","key":"10.1016\/j.biopha.2025.118921_bib214","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1039\/c6ib00167j","article-title":"Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms","volume":"8","author":"Kingsmore","year":"2016","journal-title":"Integr. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118921_bib215","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1158\/0008-5472.CAN-12-2838","article-title":"Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism","volume":"73","author":"Munson","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118921_bib216","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CMAR.S65444","article-title":"Interstitial fluid flow in cancer: implications for disease progression and treatment","author":"Munson","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2025.118921_bib217","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-62658-7_5","article-title":"CXCL12 signaling in the tumor microenvironment","author":"Portella","year":"2021","journal-title":"Tumor Microenviron. Role ChemokinesPart B"},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib218","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41419-019-1796-6","article-title":"CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells","volume":"10","author":"Ieran\u00f2","year":"2019","journal-title":"Cell death Dis."},{"key":"10.1016\/j.biopha.2025.118921_bib219","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.888431","article-title":"Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility","volume":"10","author":"Holter","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"23","key":"10.1016\/j.biopha.2025.118921_bib220","doi-asserted-by":"crossref","first-page":"13160","DOI":"10.3390\/ijms222313160","article-title":"Design of biopolymer-based interstitial therapies for the treatment of glioblastoma","volume":"22","author":"Pena","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118921_bib221","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2176\/nmc.oa.2021-0024","article-title":"Safety of Gliadel implant for malignant glioma: report of postmarketing surveillance in Japan","volume":"61","author":"Nishikawa","year":"2021","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.biopha.2025.118921_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122024","article-title":"Revealing the complexity of ultra-soft hydrogel re-swelling inside the brain","volume":"294","author":"Shur","year":"2023","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biopha.2025.118921_bib223","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/ijms21103704","article-title":"The role of selected chemokines and their receptors in the development of gliomas","volume":"21","author":"Groblewska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.biopha.2025.118921_bib224","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118921_bib225","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2147\/DDDT.S217211","article-title":"Hydrogels for peptide hormones delivery: therapeutic and tissue engineering applications","author":"Doostmohammadi","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2025.118921_bib226","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.7150\/thno.30577","article-title":"Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy","volume":"9","author":"Song","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118921_bib227","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.carbpol.2017.03.014","article-title":"Carboxymethyl cellulose\/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent","volume":"168","author":"Rasoulzadeh","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2025.118921_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122661","article-title":"An injectable and antifouling hydrogel prevents the development of abdominal adhesions by inhibiting the CCL2\/CCR2 interaction","volume":"311","author":"Wen","year":"2024","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biopha.2025.118921_bib229","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/pharmaceutics14112346","article-title":"Tumor microenvironment-based stimuli-responsive nanoparticles for controlled release of drugs in cancer therapy","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12951-022-01561-z","article-title":"Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment","volume":"20","author":"Gu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2025.118921_bib231","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jconrel.2017.03.044","article-title":"CXCR4-targeted combination therapy for the treatment of liver fibrosis","volume":"259","author":"Ullah","year":"2017","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2025.118921_bib232","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/foods11020182","article-title":"Preparation of curcumin hydrogel beads for the development of functional kulfi: a tailoring delivery system","volume":"11","author":"Sharma","year":"2022","journal-title":"Foods"},{"issue":"12","key":"10.1016\/j.biopha.2025.118921_bib233","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/carcin\/bgs312","article-title":"Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and-2","volume":"33","author":"Killian","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2025.118921_bib234","article-title":"Expressing CXCR4 in CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-\u03baB\/SDF-1\u03b1 axis to enhance anti-tumor efficacy against pancreatic cancer","author":"Ruixin","year":"2023","journal-title":"Mol. Therapy J. American Society Gene Therapy"},{"issue":"11","key":"10.1016\/j.biopha.2025.118921_bib235","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.ymthe.2023.09.010","article-title":"CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-\u03baB\/SDF-1\u03b1 axis to enhance efficacy against pancreatic cancer","volume":"31","author":"Sun","year":"2023","journal-title":"Mol. Ther."},{"issue":"46","key":"10.1016\/j.biopha.2025.118921_bib236","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201703036","article-title":"Targeted delivery of CRISPR\/Cas9-mediated cancer gene therapy via liposome-templated hydrogel nanoparticles","volume":"27","author":"Chen","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib237","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.3892\/or.2017.5601","article-title":"CRISPR\/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118921_bib238","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12951-025-03523-7","article-title":"Transdermal delivery of CRISPR\/Cas9-mediated melanoma gene therapy via polyamines-modified thermosensitive hydrogels","volume":"23","author":"Li","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"15","key":"10.1016\/j.biopha.2025.118921_bib239","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1039\/D3BM00529A","article-title":"Recent advances in stimuli-responsive polymeric carriers for controllable CRISPR\/Cas9 gene editing system delivery","volume":"11","author":"Ma","year":"2023","journal-title":"Biomater. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118921_bib240","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-024-06784-6","article-title":"CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"52","key":"10.1016\/j.biopha.2025.118921_bib241","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416909121","article-title":"CXCL12 restricts tumor growth by suppressing the Ras, ERK1\/2, c-Myc, and the immune checkpoint PD-L1 pathways","volume":"121","author":"Kravtsova-Ivantsiv","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118921_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117923","article-title":"Recent advances of affibody molecules in biomedical applications","volume":"113","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"46","key":"10.1016\/j.biopha.2025.118921_bib243","doi-asserted-by":"crossref","first-page":"31912","DOI":"10.1021\/acsnano.4c09220","article-title":"Engineering the mechanical stability of a therapeutic complex between affibody and programmed death-ligand 1 by anchor point selection","volume":"18","author":"Yang","year":"2024","journal-title":"ACS nano"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:29:21Z","timestamp":1769034561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":243,"alternative-id":["S0753332225011151"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118921","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hijacking migration: CXCL12-functionalized hydrogels as a new frontier in glioblastoma therapy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118921"}}